359 related articles for article (PubMed ID: 27067343)
1. The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome.
Avidan AY; Lee D; Park M; Jaros MJ; Shang G; Kim R
CNS Drugs; 2016 Apr; 30(4):305-16. PubMed ID: 27067343
[TBL] [Abstract][Full Text] [Related]
2. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome.
Lee DO; Buchfuhrer MJ; Garcia-Borreguero D; Avidan AY; Ahmed M; Hays R; Ondo WG; Jaros MJ; Kim R; Shang G
Sleep Med; 2016 Mar; 19():50-6. PubMed ID: 27198947
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials.
Hermanowicz N; Ellenbogen A; Irving G; Buchfuhrer M; Jaros MJ; Shang G; Kim R
CNS Drugs; 2016 May; 30(5):443-54. PubMed ID: 27095237
[TBL] [Abstract][Full Text] [Related]
5. Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbil.
Bogan RK; Lee DO; Buchfuhrer MJ; Jaros MJ; Kim R; Shang G
Ann Med; 2015 May; 47(3):269-77. PubMed ID: 25874578
[TBL] [Abstract][Full Text] [Related]
6. Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.
Walters AS; Ondo WG; Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
Clin Neuropharmacol; 2009; 32(6):311-20. PubMed ID: 19667976
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.
Lee DO; Ziman RB; Perkins AT; Poceta JS; Walters AS; Barrett RW;
J Clin Sleep Med; 2011 Jun; 7(3):282-92. PubMed ID: 21677899
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome.
Lal R; Ellenbogen A; Chen D; Zomorodi K; Atluri H; Luo W; Tovera J; Hurt J; Bonzo D; Lassauzet ML; Vu A; Cundy KC
Clin Neuropharmacol; 2012; 35(4):165-73. PubMed ID: 22664749
[TBL] [Abstract][Full Text] [Related]
9. Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies.
VanMeter SA; Kavanagh ST; Warren S; Barrett RW
CNS Drugs; 2012 Sep; 26(9):773-80. PubMed ID: 22849331
[TBL] [Abstract][Full Text] [Related]
10. Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
Inoue Y; Hirata K; Uchimura N; Kuroda K; Hattori N; Takeuchi M
Curr Med Res Opin; 2013 Jan; 29(1):13-21. PubMed ID: 23121149
[TBL] [Abstract][Full Text] [Related]
11. Predictors of clinical response in a double-blind placebo controlled crossover trial of gabapentin enacarbil for restless legs syndrome.
Winkelman JW; Jaros MJ
Sleep Med; 2018 Aug; 48():1-7. PubMed ID: 29807228
[TBL] [Abstract][Full Text] [Related]
12. Gabapentin Enacarbil: A Review in Restless Legs Syndrome.
Kim ES; Deeks ED
Drugs; 2016 May; 76(8):879-87. PubMed ID: 27146056
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin enacarbil: in patients with restless legs syndrome.
Scott LJ
CNS Drugs; 2012 Dec; 26(12):1073-83. PubMed ID: 23179641
[TBL] [Abstract][Full Text] [Related]
14. Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study.
Bogan RK; Bornemann MA; Kushida CA; Trân PV; Barrett RW;
Mayo Clin Proc; 2010 Jun; 85(6):512-21. PubMed ID: 20511481
[TBL] [Abstract][Full Text] [Related]
15. Effect of prior exposure to dopamine agonists on treatment with gabapentin enacarbil in adults with moderate-to-severe primary restless legs syndrome: pooled analyses from 3 randomized trials.
Ondo WG; Hermanowicz N; Borreguero DG; Jaros MJ; Kim R; Shang G
J Clin Mov Disord; 2015; 2():9. PubMed ID: 26788345
[TBL] [Abstract][Full Text] [Related]
16. Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: results from two double-blind, multicenter, placebo-controlled clinical trials.
Canafax DM; Bhanegaonkar A; Bharmal M; Calloway M
BMC Neurol; 2011 Apr; 11():48. PubMed ID: 21527006
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and safety of gabapentin enacarbil in Japanese restless legs syndrome patients.
Inoue Y; Uchimura N; Kuroda K; Hirata K; Hattori N
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):251-7. PubMed ID: 22036917
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.
Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
Neurology; 2009 Feb; 72(5):439-46. PubMed ID: 19188575
[TBL] [Abstract][Full Text] [Related]
19. Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome.
Winkelman JW; Bogan RK; Schmidt MH; Hudson JD; DeRossett SE; Hill-Zabala CE
Mov Disord; 2011 Sep; 26(11):2065-72. PubMed ID: 21611981
[TBL] [Abstract][Full Text] [Related]
20. A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.
Sun Y; van Valkenhoef G; Morel T
Curr Med Res Opin; 2014 Nov; 30(11):2267-78. PubMed ID: 25050588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
